Novo Nordisk Currently Up Nine Consecutive Days, on Pace for Longest Winning Streak Since December 2022 -- Data Talk

Dow Jones
05/12

Novo Nordisk A/S Sponsored ADR Class B (NVO) is currently at $46.67, up $0.27 or 0.58%

 

--Would be highest close since Feb. 20, 2026, when it closed at $47.42

--On pace for largest percent increase since May 11, 2026, when it rose 0.72%

--Currently up nine consecutive days; up 15.84% over this period

--Longest winning streak since Dec. 5, 2022, when it rose for nine straight trading days

--Best nine day stretch since the nine days ending Jan. 13, 2026, when it rose 16.44%

--Up 10.54% month-to-date

--Down 8.27% year-to-date

--Down 68.23% from its all-time closing high of $146.91 on June 25, 2024

--Down 28.64% from 52 weeks ago (May 13, 2025), when it closed at $65.40

--Down 42.42% from its 52-week closing high of $81.05 on June 12, 2025

--Up 32.25% from its 52-week closing low of $35.29 on March 30, 2026

--Traded as high as $47.11

--Up 1.53% at today's intraday high

 

All data as of 10:44:32 AM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

May 12, 2026 10:47 ET (14:47 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10